Associated Papers
Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants.
Aykut A et al.
Immunologic Research, 2024
Correlation of CTLA-4 polymorphism and the risk of gastric cancer in a Chinese Bai population.
Yan P et al.
International Journal of Immunogenetics, 2023
Association of cytotoxic T lymphocyte-associated protein 4 gene -1772T/C polymorphism with gastric cancer risk: A prisma-compliant meta-analysis.
Zhuo C et al.
Medicine, 2020
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.
Wagner M et al.
Frontiers in Immunology, 2020
33519815 (PubMed )
Supplement: Table_1.docx
Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study.
Yang J et al.
Medicine, 2019
CTLA4 tagging polymorphisms and risk of colorectal cancer: a case-control study involving 2,306 subjects.
Zou C et al.
Oncotargets and Therapy, 2018
Association between ICOS polymorphisms and risk of colorectal cancer: a case-control study involving 2,606 subjects.
Jiang J et al.
International Journal of Clinical and Experimental Pathology, 2018
Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma.
Tang W et al.
Scandinavian Journal of Immunology, 2016
Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.
Yan Q et al.
Plos One, 2013
Genetic markers in acquired haemophilia.
Oldenburg J et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2010
Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.
Pavlova A et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2008
SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis.
Oertelt S et al.
Clinical & Developmental Immunology, 2005
Select a paper to view details